Skip to main content
. 2018 Oct 24;10(3):210–216. doi: 10.1136/flgastro-2018-101049

Table 3.

DAA treatment regimen according to genotype

Treatment regimen Genotype 1 (%) Genotype 2 (%) Genotype 3(%) Genotype 4 (%)
SOF/LED 85 50
SOF/VEL 9 26 22
SOF/DAC 3 78
SOF/RIB 74
ELB/GRA 50
OMB/PAR/DAS 3

DAA, direct- acting antiviral agent;  DAC, daclatasvir; DAS, dasabuvir; ELB, elbasvir; GRA, grazoprevir; LED, ledispavir; OMB, ombitasvir; PAR, paritaprevir; RIB, ribavirin; SOF, sofosbuvir; VEL, velapatasvir.